Zinia Chakraborty

Title: Innovations of Zinia Chakraborty in Therapeutic Protein Production

Introduction

Zinia Chakraborty is a notable inventor based in Hyderabad, Telangana, India. She has made significant contributions to the field of therapeutic protein production, holding three patents that showcase her innovative approaches. Her work primarily focuses on processes that enhance the purity and yield of essential proteins derived from human plasma.

Latest Patents

One of her latest patents is titled "Chromatographic process for producing high purity fibrinogen and thrombin." This invention relates to a chromatographic method for obtaining purified fibrinogen and thrombin from human plasma. The resulting preparations contain plasminogen in amounts less than 1 µg/mL, which eliminates the need for a proteolytic inhibitor, such as aprotinin, in fibrin sealant kits used for human therapeutic applications.

Another significant patent is the "Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma." This invention outlines an integrated process for isolating and purifying plasma-derived clotting factors, albumin, and immunoglobulin without the use of ethanol precipitation. The process involves sequential chromatography steps, including gel filtration, anion exchange, and cation exchange chromatographies, followed by viral inactivation and removal steps. This method is advantageous as it is mild and does not denature or aggregate proteins, providing high yields of therapeutic-grade plasma proteins.

Career Highlights

Zinia Chakraborty is currently associated with Hemarus Therapeutics Limited, where she continues to advance her research in therapeutic protein production. Her innovative work has positioned her as a key figure in the field, contributing to the development of safer and more effective therapeutic products.

Collaborations

Zinia collaborates with talented professionals, including Ashok Kumar Nuvula and Uma Devi Komath, who contribute to her research endeavors. Their combined expertise enhances the potential for groundbreaking advancements in therapeutic applications.

Conclusion

Zinia Chakraborty's contributions to the field of therapeutic protein production through her innovative patents demonstrate her commitment to improving human health. Her work not only advances scientific knowledge but also has practical implications for therapeutic applications.